API Methazolamide

Methazolamide More Info

Methazolamide is a prescription medication classified primarily as a carbonic anhydrase inhibitor (CAI), widely used in clinical practice to manage specific medical conditions related to fluid regulation and intraocular pressure. Below is a concise, professional introduction covering its core information—aligned with needs for clear, actionable details (e.g., for client communication or product context in the pharmaceutical/chemical field).

1. Basic Information

Its generic name is Methazolamide, with a CAS number of 554-57-4 and a molecular formula of C₅H₈N₄O₃S₂. In terms of mechanism of action, it works by inhibiting the enzyme “carbonic anhydrase,” which is present in organs like the kidneys and eyes. This inhibition reduces the production of aqueous humor (the fluid inside the eye) and promotes the excretion of sodium and potassium bicarbonate in urine, ultimately lowering intraocular pressure and inducing mild diuresis (fluid loss).

2. Main Medical Uses

Its clinical applications focus on conditions where reducing intraocular pressure or mild diuresis is critical:

Glaucoma: It is a first-line treatment for open-angle glaucoma (the chronic type) and secondary glaucoma (e.g., caused by eye injury or surgery). By lowering the pressure inside the eye, it helps prevent damage to the optic nerve.

Acute Mountain Sickness (AMS): It is used to prevent or treat mild-to-moderate AMS—symptoms include headache, nausea, and dizziness—in people who ascend to high altitudes (e.g., above 2,500 meters) quickly.

Edema: It is occasionally used as an adjunct treatment for edema (fluid buildup) caused by heart failure or kidney issues, though it is less potent than other diuretics (e.g., furosemide).

3. Key Safety & Administration Notes

Dosage Form: It is available as oral tablets, with common strengths of 25 mg and 50 mg. It is usually taken twice daily, but the specific dosage may be adjusted based on the patient’s condition (e.g., severity of glaucoma, altitude for AMS prevention) and doctor’s guidance.

Contraindications: It is not suitable for patients with a history of hypersensitivity to methazolamide, other carbonic anhydrase inhibitors (e.g., acetazolamide), or sulfonamide-derived drugs. It is also contraindicated in patients with severe kidney or liver dysfunction, adrenal insufficiency, or hyperchloremic acidosis (a type of electrolyte imbalance).

Common Side Effects: Mild side effects may include dizziness, fatigue, loss of appetite, and a bitter or metallic taste in the mouth. More serious but rare side effects include severe allergic reactions, blood disorders (e.g., leukopenia), or liver enzyme elevation—patients should seek medical attention immediately if these occur.

Precautions: During treatment, doctors may monitor the patient’s electrolyte levels (e.g., sodium, potassium) and kidney function regularly. Patients with diabetes should note that methazolamide may slightly increase blood glucose levels, requiring closer monitoring of blood sugar. Additionally, it may cause drowsiness, so patients should avoid driving or operating heavy machinery until they know how the medication affects them.